ACRX
Acelrx Pharmaceuticals Inc
Halal Rating :
Last Price
$0.62
Last updated:
Market Cap
-
7D Change
7.6%
1 Year Change
-32.02%
Company Overview
Exchange
Next Earnings Date
AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on developing and commercializing therapies for the treatment of acute pain. The company's main product candidate is DSUVIA (sufentanil sublingual tablet), which is designed for the management of acute pain severe enough to require an opioid analgesic for adult patients in certified medically supervised healthcare settings.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Acelrx Pharmaceuticals Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.